AbbVie : ABBV

All AbbVie Articles

583 Articles

Jon C. Ogg | Sep 28, 2019 at 9:10 AM EDT

6 Large-Cap and Mega-Cap Stocks Where Analysts See Large Upside Potential

The week of September 28 saw many analyst upgrades and positive calls in blue-chip stocks. Here are six that received…

Lee Jackson | Sep 27, 2019 at 10:45 AM EDT

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter…

Lee Jackson | Sep 26, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk, Whirlpool and More

Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk and…

Chris Lange | Sep 25, 2019 at 9:20 AM EDT

Short Sellers Grow More Selective in Big Pharma

The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Sep 12, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Ally, Anthem, Caterpillar, CVS, Deere, Oracle, PayPal, Rite Aid, Square, Uber, UnitedHealth and More

The top analyst upgrades, downgrades and initiations for Thursday included AbbVie, Ally Financial, Anthem, Caterpillar, CVS Health, Deere, Oracle, PayPal,…

Chris Lange | Sep 12, 2019 at 8:35 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The August 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 4, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Camping World, Cleveland-Cliffs, Coupa, Dollar General, DuPont, Nike, Roku, StoneCo and More

The top analyst upgrades, downgrades and initiations for Wednesday included AbbVie, Camping World, Cleveland-Cliffs, Coupa Software, Dollar General, DuPont, Nike,…

Chris Lange | Aug 27, 2019 at 8:35 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Aug 26, 2019 at 7:40 AM EDT

5 Incredible Blue Chip Stocks With 6% or Higher Dividends

These five companies all pay at least a 6% dividend and offer a reasonable degree of safety. Even if a…

Jon C. Ogg | Aug 20, 2019 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Bio-Rad, Dell, HP, Jumia, Nabriva, PG&E, Salesforce, Sarepta and More

The included AbbVie, Beyond Meat, Bio-Rad Laboratories, Dell Technologies, HP, Jumia Technologies, Nabriva Therapeutics, PG&E, Salesforce.com and Sarepta Therapeutics.

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:40 AM EDT

Major Pharma Sees Rising Tide in Short Interest

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Aug 8, 2019 at 1:05 PM EDT

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Of the 40 worst performers in the S&P 500 so far in 2019, 11 are tied to oil and gas,…

Chris Lange | Jul 25, 2019 at 8:35 AM EDT

Short Sellers Up the Ante in Big Pharma

The July 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 11, 2019 at 9:45 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

1 … 15 16 17 18 19 … 39

AbbVie : ABBV

All AbbVie Articles

6 Large-Cap and Mega-Cap Stocks Where Analysts See Large Upside Potential

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

Top Analyst Upgrades and Downgrades: AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk, Whirlpool and More

Short Sellers Grow More Selective in Big Pharma

Top Analyst Upgrades and Downgrades: AbbVie, Ally, Anthem, Caterpillar, CVS, Deere, Oracle, PayPal, Rite Aid, Square, Uber, UnitedHealth and More

Short Sellers Can’t Make Up Their Minds on Big Pharma

Top Analyst Upgrades and Downgrades: AbbVie, Camping World, Cleveland-Cliffs, Coupa, Dollar General, DuPont, Nike, Roku, StoneCo and More

Big Pharma Sees a Rising Tide in Short Interest

5 Incredible Blue Chip Stocks With 6% or Higher Dividends

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Bio-Rad, Dell, HP, Jumia, Nabriva, PG&E, Salesforce, Sarepta and More

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Short Sellers Up the Ante in Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

AbbVie : ABBV

All AbbVie Articles

6 Large-Cap and Mega-Cap Stocks Where Analysts See Large Upside Potential

Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4

Top Analyst Upgrades and Downgrades: AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk, Whirlpool and More

Short Sellers Grow More Selective in Big Pharma

Top Analyst Upgrades and Downgrades: AbbVie, Ally, Anthem, Caterpillar, CVS, Deere, Oracle, PayPal, Rite Aid, Square, Uber, UnitedHealth and More

Short Sellers Can’t Make Up Their Minds on Big Pharma

Top Analyst Upgrades and Downgrades: AbbVie, Camping World, Cleveland-Cliffs, Coupa, Dollar General, DuPont, Nike, Roku, StoneCo and More

Big Pharma Sees a Rising Tide in Short Interest

5 Incredible Blue Chip Stocks With 6% or Higher Dividends

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Bio-Rad, Dell, HP, Jumia, Nabriva, PG&E, Salesforce, Sarepta and More

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Short Sellers Up the Ante in Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation